Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 14941–14960 of 17,529 recalls

November 16, 2013· Tower Pharmacy and Compounding

Recalled Item: Phenylephrine Nasal 1% Spray

The Issue: Microbial Contamination of Non Sterile Products: Tower Pharmacy

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 15, 2013· Actavis Inc

Recalled Item: BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 14, 2013· Teva Pharmaceuticals USA, Inc.

Recalled Item: Fluconazole Oral Suspension

The Issue: Failed Stability Specifications: this product is below specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 13, 2013· Forest Pharmaceuticals Inc

Recalled Item: Namenda XR (memantine HCl)

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 13, 2013· Brookfield Prescription Center Inc

Recalled Item: Glycopyrrolate (MDV) 0.2 MG/ML Injectable

The Issue: Non-Sterility: One lot of Glycopyrrolate solution for injection

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
November 13, 2013· Forest Pharmaceuticals Inc

Recalled Item: Namenda XR (memantine HCl)

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 13, 2013· Forest Pharmaceuticals Inc

Recalled Item: Namenda XR (memantine HCl)

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 12, 2013· Baxter Healthcare Corp.

Recalled Item: 10%

The Issue: Lack of Assurance of Sterility; Drug product leaking

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 8, 2013· Teva Pharmaceuticals USA, Inc.

Recalled Item: Valacyclovir Hydrochloride Tablets

The Issue: Presence of Foreign Tablets/Capsules: Potential of Pravastatin tablet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 8, 2013· Fresenius Kabi USA, LLC

Recalled Item: PACLITAXEL INJECTION

The Issue: Labeling: Incorrect or Missing Package Insert- Missing text

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 7, 2013· Deseo Rebajar

Recalled Item: Adipotrim XT

The Issue: Undeclared Api

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
November 7, 2013· West-Ward Pharmaceutical Corp.

Recalled Item: Carisoprodol Tablets

The Issue: Presence of Foreign Substance; heavy metals (chromium, titanium

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 6, 2013· GlaxoSmithKline, LLC.

Recalled Item: Sumatriptan Succinate Injection

The Issue: Lack of Assurance of Sterility: A small number

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 6, 2013· Actavis Elizabeth LLC

Recalled Item: Clonazepam Tablets

The Issue: Subpotent Drug: During routine stability testing one tablet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 6, 2013· Sandoz Inc

Recalled Item: Bumetanide Tablets USP 0.5 mg. Rx Only

The Issue: Failed Moisture Limit; Out of Specification (OOS) results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 6, 2013· Airgas Medical Services

Recalled Item: Carbon Dioxide

The Issue: Labeling: Not Elsewhere Classified; Due to an error

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 6, 2013· GlaxoSmithKline, LLC.

Recalled Item: Imitrex STATdose System

The Issue: Lack of Assurance of Sterility: A small number

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 5, 2013· Greenstone LLC

Recalled Item: sertraline HCl tablets

The Issue: Labeling: Incorrect or Missing Lot No. and/or Exp

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
November 4, 2013· Pfizer Inc.

Recalled Item: Glucotrol XL (glipizide) extended release tablets

The Issue: Failed Dissolution Specification; 8 hr stability timepoint

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 4, 2013· Alexion Pharmaceuticals, Inc.

Recalled Item: Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only

The Issue: Presence of Particulate Matter: Failed the appearance test

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund